ALFA FinderBSE filing, NSE: APOLLO. Summary written from the filing by ALFA Finder's alert engine.
Apollo Micro Systems Ltd: key numbers
- Share price
- ₹475.60
- Market cap
- ₹16,993 Cr
- Revenue (annual)
- ₹904.3 Cr
- Net profit (annual)
- ₹112.9 Cr
- P/E (TTM)
- 122.6×Sector 52.1×
- Promoter holding
- 49.98%+0.00% QoQ
- FII holding
- 5.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Micro Systems Ltd
All →Apollo Micro Systems Acquisition
Apollo Micro Systems corrected its 2 November 2026 disclosure on acquiring shares of Premier Explosives. The acquired share count is now 1,39,77,911 and oversubscription is 5.45%.
Apollo Micro Systems Preferential Issue
Apollo Micro Systems Ltd issued clarifications regarding its EGM notice for a proposed preferential issue of shares and warrants. The updates include revised allottee details and valuation compliance for investors.
Apollo Micro Systems Open Offer: ₹986.4 Cr
Apollo Micro Systems deposited Rs.986.35 Crore in escrow for the open offer to Premier Explosives' public shareholders. The offer closed on 26 October 2026, oversubscribed by 1.41%.
- Value
- ₹986.4 Cr
Apollo Micro Systems Earnings Call Transcript: Key Takeaways
Apollo reported record-breaking performance driven by defense indigenization, yet consolidated margins are temporarily dampened by the transition of loss-making subsidiary Ideal Explosives.
- Call
- Guides 45% growth
Apollo Micro Systems Business Update
Apollo Micro Systems' MD issued a shareholder letter on Q2 FY27 performance and missile-technology expansion. It cites a new ShauryAstra subsidiary for complete weapon systems.
Apollo Micro Systems Results Update
Apollo Micro Systems reported record Q2 FY27 standalone revenue of ₹306 Crore, up 97% quarter-on-quarter. H1 FY27 consolidated revenue rose 78% year-on-year to ₹639 Crore.
Other other announcement announcements
All →Religare Enterprises Other Announcement
Religare Enterprises filed CARE Ratings' monitoring agency report for the quarter ended September 30, 2026, on its Rs 1,500 crore preferential warrant issue. The report states proceeds were used per the offer document with no deviation.
Optivalue Tek Consulting Other Announcement
Optivalue Tek filed Acuité's half-yearly monitoring report on IPO proceeds for H1 FY2026-27. No deviation from the offer objects was observed.
5Paisa Capital Other Announcement
5paisa Capital Ltd filed its quarterly shareholding pattern under Regulation 31(1)(c). It reports routine holding figures with no new transaction or corporate event.
Chennai Meenakshi Multispeciality Hospital Other Announcement
Chennai Meenakshi Multispeciality Hospital issued a duplicate share certificate for 100 shares to Inder Chand Kothari L under folio 00008717. The intimation is routine share-certificate paperwork with no transaction or money involved.
Axel Polymers Other Announcement
Axel Polymers reports no deviation in utilisation of its Rs 11.18 Crore preferential issue proceeds for the quarter ended 30 September 2026. This is a routine Regulation 32 statement of deviation with a clean auditor certificate.
360 One Wam Other Announcement
360 ONE WAM disclosed PIT sales by five insiders on 12 November 2026, totalling about Rs 3.55 Crore. The sellers are designated persons, KMP and an employee's relative, with no promoter involved.
- Value
- ₹3.55 Cr